StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Proteome Sciences plc
LSE:PRM.L
Sector
Location
Market Cap
USD 12.06 M
Share Price
USD 0.04
Avg Daily Volume
250,215
Change (1 day)
-0.49%
Change (1 year)
-6.50%
Change (YTD)
-3.97%
Proteome Sciences plc Shareholders' Equity for the year ending December 31, 2024: USD -8.15 M
Proteome Sciences plc Shareholders' Equity is USD -8.15 M for the year ending December 31, 2024, a 108.98% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Proteome Sciences plc Shareholders' Equity for the year ending December 31, 2023 was USD -3.90 M, a -100.00% change year over year.
-
Proteome Sciences plc Shareholders' Equity for the year ending December 31, 2022 was USD 82.54 B, a -11.67% change year over year.
-
Proteome Sciences plc Shareholders' Equity for the year ending December 31, 2021 was USD 93.44 B, a 4.00% change year over year.
-
Proteome Sciences plc Shareholders' Equity for the year ending December 31, 2020 was USD 89.85 B, a 5.25% change year over year.
Competitors
Natera, Inc.
USD 138.90
NTRA
-2.17
-1.54%
Illumina, Inc.
USD 109.30
ILMN
+1.66
1.54%
Tempus AI, Inc.
USD 64.49
TEM
+1.15
1.82%
Veracyte, Inc.
USD 25.25
VCYT
+1.66
7.04%
Schrödinger, Inc.
USD 22.23
SDGR
-0.26
-1.16%
Azenta, Inc.
USD 34.43
AZTA
+0.47
1.38%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Natera, Inc.
USD 138.90
NTRA
-2.17
-1.54%
Illumina, Inc.
USD 109.30
ILMN
+1.66
1.54%
Tempus AI, Inc.
USD 64.49
TEM
+1.15
1.82%
Veracyte, Inc.
USD 25.25
VCYT
+1.66
7.04%
Schrödinger, Inc.
USD 22.23
SDGR
-0.26
-1.16%
Azenta, Inc.
USD 34.43
AZTA
+0.47
1.38%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%